ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $240 | -42.6% | 321,360 | -25.4% | 0.00% | -100.0% |
Q2 2023 | $418 | +5.6% | 430,555 | -4.9% | 0.00% | 0.0% |
Q1 2023 | $396 | -21.9% | 452,860 | -14.9% | 0.00% | 0.0% |
Q4 2022 | $507 | -99.9% | 532,260 | -27.1% | 0.00% | 0.0% |
Q3 2022 | $804,000 | -26.4% | 730,598 | -19.1% | 0.00% | 0.0% |
Q2 2022 | $1,093,000 | +40.3% | 903,100 | +149.3% | 0.00% | 0.0% |
Q1 2022 | $779,000 | +20.4% | 362,314 | +564.8% | 0.00% | 0.0% |
Q4 2021 | $647,000 | -21.6% | 54,500 | +2.4% | 0.00% | 0.0% |
Q3 2021 | $825,000 | – | 53,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 2,320,381 | $2,808,000 | 4.30% |
Pivotal bioVenture Partners Investment Advisor LLC | 743,215 | $899,000 | 0.45% |
Vivo Capital, LLC | 3,547,030 | $4,292,000 | 0.43% |
TANG CAPITAL MANAGEMENT LLC | 1,547,710 | $1,873,000 | 0.28% |
Newtyn Management, LLC | 962,088 | $1,164,000 | 0.22% |
EcoR1 Capital, LLC | 3,948,360 | $4,778,000 | 0.16% |
Boxer Capital, LLC | 1,526,048 | $1,847,000 | 0.12% |
Novo Holdings A/S | 1,950,000 | $2,360,000 | 0.12% |
HHLR ADVISORS, LTD. | 2,365,064 | $2,862,000 | 0.06% |
SILVERARC CAPITAL MANAGEMENT, LLC | 58,392 | $71,000 | 0.02% |